⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL104041 | 0.80 | — | — | |
| SCHEMBL14456621 | 0.80 | — | — | |
| SCHEMBL2134909 | 0.75 | — | — | |
| SCHEMBL553855 | 0.75 | — | — | |
| SCHEMBL20836269 | 0.75 | — | — | |
| SCHEMBL5076821 | 0.75 | — | — | |
| SCHEMBL25700 | 0.75 | — | — | |
| SCHEMBL803435 | 0.75 | — | — | |
| SCHEMBL17875211 | 0.75 | — | — | |
| SCHEMBL6825241 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024077244-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS | HOTSPOT THERAPEUTICS, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| WO-2024015863-A1 | CBL-B INHIBITOR, COMPOSITIONS COMPRISING A CBL-B INHIBITOR IN A METHOD OF TREATING A DISEASE ASSOCIATED WITH CELL PROLIFERATION | HOTSPOT THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | WO | disclosed |
| US-20230250046-A1 | FLUORINATED CARBOXYLIC ACID SALT COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2023-08-10 | — | — | US | disclosed |
| EP-3453705-B1 | PHOTOISOMERIC COMPOUNDS AND DEVICE COMPRISING SAME | UNIV BEIJING (CN) | 2023-07-12 | — | — | EP | disclosed |
| US-11664534-B2 | Electrolytic solution, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2023-05-30 | — | — | US | disclosed |
| WO-2022221704-A1 | COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER | HOTSPOT THERAPEUTICS, INC. (US) | 2022-10-20 | — | — | WO | disclosed |
| US-11145901-B2 | Electrolyte and electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2021-10-12 | — | — | US | disclosed |
| EP-3667804-B1 | ELECTROLYTE SOLUTION CONTAINING UNSATURATED CYCLIC CARBONATES, ELECTROCHEMICAL DEVICE AND LITHIUM-ION SECONDARY BATTERY COMPRISING THE SAME | DAIKIN IND LTD (JP) | 2021-04-21 | — | — | EP | disclosed |
| EP-3750884-A1 | NOVEL FLUORINATED UNSATURATED CYCLIC CARBONATE AND PROCESS FOR PRODUCING THE SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2020-12-16 | — | — | EP | disclosed |
| EP-3667804-A1 | ELECTROLYTE SOLUTION CONTAINING UNSATURATED CYCLIC CARBONATES, ELECTROCHEMICAL DEVICE AND LITHIUM-ION SECONDARY BATTERY COMPRISING THE SAME | DAIKIN INDUSTRIES, LIMITED (JP) | 2020-06-17 | — | — | EP | disclosed |
| US-7264329-B2 | Inkjet recording head and inkjet recording device | FUJIFILM CORPORATION (JP) | 2007-09-04 | — | — | US | disclosed |
| US-20050053552-A1 | Phase shift colloids as ultrasound contrast agents | QUAY STEVEN C (US) | 2005-03-10 | — | — | US | disclosed |
| US-6569404-B1 | Aqueous colloidal suspension, dispersed phase is gas microbubbles of perfluoropropane, perfluorobutane, perfluoropentane, perfluorohexane or sulfur hexafluoride; fluorinated amphiphile for stabilizing microbubbles | AMERSHAM HEALTH A/S (NO) | 2003-05-27 | — | — | US | disclosed |
| US-6245319-B1 | Colloidal dispersions of perfluoropentane | SONUS PHARMACEUTICALS, INC. | 2001-06-12 | — | — | US | disclosed |
| EP-0680341-B1 | PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS | SONUS PHARMA INC (US) | 2001-05-09 | — | — | EP | disclosed |
| EP-1038535-A2 | Use of selected perfluorocarbons for the preparation of diagnostic ultrasound contrast agents | SONUS PHARMACEUTICALS, INC. (US) | 2000-09-27 | — | — | EP | disclosed |
| US-5876696-A | Composition comprising a fluorine containing surfactant and perfluoropentane for ultrasound | SONUS PHARMACEUTICALS, INC. (US) | 1999-03-02 | — | — | US | disclosed |
| US-5558853-A | WATER IMMISCIBLE FLUORINE COMPOUND | SONUS PHARMACEUTICALS (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0680341-A1 | PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS | SONUS PHARMACEUTICALS, INC. (US) | 1995-11-08 | — | — | EP | disclosed |
| WO-1994016739-A1 | PHASE SHIFT COLLOIDS AS ULTRASOUND CONTRAST AGENTS | SONUS PHARMACEUTICALS, INC. (US) | 1994-08-04 | — | — | WO | disclosed |